Mounjaro contraception advice updated

Nicholas O’Donoghue 01/12/2025

caution warning danger sign thunderstorm

Product information to recommend patients taking Mounjaro switch to non-oral contraceptives for four weeks after each dose An investigation by the Therapeutic Goods Administration (TGA) into the potential for reduced effectiveness of oral contraceptives during initiation or dose escalations with Mounjaro (tirzepatide) has found that the association could not be ruled out. The regulator announced that “as a precautionary measure, the product information

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

This web site is intended for Australian pharmacy professionals and is not a substitute for independent professional advice. Information and interactions contained in this website are for information purposes only and are not intended to be used to diagnose, treat, cure or prevent any disease. Further the accuracy, currency and completeness of the information available on this web site cannot be guaranteed. APPco Pty Ltd, its affiliates and their respective servants and agents do not accept any liability for any injury, loss or damage incurred by use of or reliance on the information made available via or through ajp.com.au whether arising from negligence or otherwise.

Mounjaro contraception advice updated

Previous TGA updates product warning for GLP-1s

Next First technician wins AdPha Medal of Merit

MENU

ajp.com.au

Previous TGA updates product warning for GLP-1s

Next First technician wins AdPha Medal of Merit

MENU

ajp.com.au

Tags

Hi there! 👋 Looks like you’re not logged in.